Open AccessRespecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers
Author(s) -
Hiromichi Ebi,
Sosipatros A. Boikos,
Anthony C. Faber
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.08.122
Subject(s) - osimertinib , gefitinib , erlotinib , medicine , t790m , oncology , protein tyrosine kinases , lung cancer , lung , erlotinib hydrochloride , cell , epidermal growth factor receptor , cancer research , cancer , tyrosine kinase , receptor , genetics , biology